Rodrigo Moore-Carrasco Selected Research

N- (3,5- bis(trifluoromethyl)phenyl)- 2- chloro- 4- (trifluoromethyl)pyrimidine- 5- carboxamide

4/2009	Both AP-1 and NF-kappaB seem to be involved in tumour growth in an experimental rat hepatoma.
5/2007	The AP-1/NF-kappaB double inhibitor SP100030 can revert muscle wasting during experimental cancer cachexia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rodrigo Moore-Carrasco Research Topics

Disease

9	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2015 - 11/2006
7	Neoplasms (Cancer) 07/2021 - 08/2004
6	Insulin Resistance 01/2021 - 11/2006
6	Cachexia 01/2008 - 08/2004
4	Dyslipidemias (Dyslipidemia) 01/2014 - 05/2009
4	Body Weight (Weight, Body) 05/2010 - 05/2007
3	Atherosclerosis 01/2015 - 01/2014
3	Hypertension (High Blood Pressure) 12/2013 - 05/2008
3	Abdominal Obesity 12/2013 - 05/2008
2	Cardiovascular Diseases (Cardiovascular Disease) 12/2013 - 01/2013
2	Metabolic Diseases (Metabolic Disease) 12/2013 - 01/2013
2	Inflammation (Inflammations) 01/2013 - 08/2004
2	Thrombosis (Thrombus) 01/2013 - 01/2005
2	Thrombophilia 01/2010 - 11/2006
2	Ascites 04/2009 - 05/2007
2	Hepatocellular Carcinoma (Hepatoma) 04/2009 - 05/2007
1	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2021
1	Myocardial Infarction 11/2019
1	Stomach Neoplasms (Stomach Cancer) 10/2019
1	Atherosclerotic Plaque (Atheroma) 01/2014
1	Hyperlipidemias (Hyperlipidemia) 01/2013
1	Glucose Intolerance 05/2009
1	Type 2 Diabetes Mellitus (MODY) 05/2008
1	Thrombocytopenia (Thrombopenia) 01/2005
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2005
1	Wasting Syndrome (Wasting Disease) 09/2004
1	Infections 08/2004
1	Neurologic Manifestations (Neurological Manifestations) 08/2004

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2010 - 09/2004
3	Apolipoproteins E (ApoE)IBA 01/2015 - 01/2014
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2013 - 05/2008
3	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 04/2009 - 01/2006
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2013
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2014 - 05/2011
2	PPAR gammaIBA 12/2013 - 01/2008
2	Biological ProductsIBA 01/2013 - 08/2004
2	Blood Coagulation Factors (Coagulation Factor)IBA 01/2010 - 11/2006
2	HDL CholesterolIBA 05/2009 - 11/2006
2	LDL CholesterolIBA 05/2009 - 11/2006
2	NF-kappa B (NF-kB)IBA 04/2009 - 05/2007
2	N- (3,5- bis(trifluoromethyl)phenyl)- 2- chloro- 4- (trifluoromethyl)pyrimidine- 5- carboxamideIBA 04/2009 - 05/2007
2	CytokinesIBA 05/2007 - 08/2004
1	MTOR InhibitorsIBA 07/2021
1	Adenosine (Adenocard)FDA LinkGeneric 01/2021
1	palbociclibIBA 10/2019
1	Pharmaceutical PreparationsIBA 10/2019
1	RNA (Ribonucleic Acid)IBA 10/2019
1	ApolipoproteinsIBA 01/2014
1	Interleukin-6 (Interleukin 6)IBA 01/2014
1	Sirtuin 1IBA 12/2013
1	LigandsIBA 12/2013
1	AdipokinesIBA 12/2013
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2013
1	Transcription Factors (Transcription Factor)IBA 01/2012
1	CarbohydratesIBA 01/2012
1	CCAAT-Enhancer-Binding ProteinsIBA 01/2012
1	Sterol Regulatory Element Binding ProteinsIBA 01/2012
1	ElementsIBA 01/2012
1	Carrier Proteins (Binding Protein)IBA 01/2012
1	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 05/2011
1	LipidsIBA 05/2010
1	oxidized low density lipoproteinIBA 05/2009
1	CD40 Ligand (CD40L)IBA 05/2009
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 05/2009
1	Plasminogen Activators (Plasminogen Activator)IBA 03/2009
1	Fibrinogen (Factor I)FDA Link 03/2009
1	Triglycerides (Triacylglycerol)IBA 05/2008
1	Adenosine Triphosphate (ATP)IBA 05/2008
1	Fibric Acids (Fibrates)IBA 05/2008
1	Insulin (Novolin)FDA Link 05/2008
1	Protein Isoforms (Isoforms)IBA 05/2008
1	ThiazolidinedionesIBA 05/2008
1	GW 1929IBA 01/2008
1	Proteasome Endopeptidase Complex (Proteasome)IBA 05/2007
1	UbiquitinIBA 05/2007
1	Ubiquitin-Conjugating EnzymesIBA 05/2007
1	EnzymesIBA 05/2007
1	HDL LipoproteinsIBA 11/2006
1	Lipoproteins (Lipoprotein)IBA 11/2006
1	Plasminogen InactivatorsIBA 11/2006
1	VLDL LipoproteinsIBA 11/2006
1	Heparin (Liquaemin)FDA LinkGeneric 01/2005
1	Fc gamma receptor IIAIBA 01/2005
1	AntibodiesIBA 01/2005
1	DNA (Deoxyribonucleic Acid)IBA 09/2004
1	Muscle Proteins (Muscle Protein)IBA 09/2004
1	Caspase 3 (Caspase-3)IBA 09/2004
1	Formoterol Fumarate (Oxis)FDA Link 09/2004
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2004
1	Ion Channels (Ion Channel)IBA 08/2004

Therapy/Procedure

3	Therapeutics 07/2021 - 01/2005
1	Renal Dialysis (Hemodialysis) 01/2005